TCT-533 Impact of High High-Density Lipoprotein-Cholesterol on 1-year Outcome of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  by Cho, Yun-Kyeong et al.
non-percutaneous coronary intervention (PCI) facility. ACC/AHA Clinical AMI Perfor-
mance Measures recommend a benchmark of 30 minutes DIDO time. However, recent
studies indicate this is difficult to achieve. Our goal was to evaluate the effect of various
DIDO times on clinical outcomes.
Methods: Using a comprehensive prospective regional STEMI program database, we
evaluated the outcome of STEMI patients based on DIDO times of 30 minutes, 30-45
minutes, 46-60 minutes, 61-90 minutes, and 90 minutes.
Results: Of 3,435 consecutive STEMI patients who presented to the Minneapolis Heart
Institute at Abbott Northwestern Hospital regional STEMI system 4/03 to 12/11, 2,589
were transferred from non-PCI facilities (Zone 1 0-60 miles, Zone 2 60-210 miles). The
baseline characteristics and outcomes for the DIDO groups are shown in Table 1. Longer
DIDO times occurred in patients with increased age, history of diabetes, presentation
during off-peak hours, self-transfer to non-PCI hospital, no intervention performed, and
Zone 2 patients. As expected, patients with shorter DIDO times were more likely to have
a door to balloon time 120 minutes, but there was basically no difference in 30 and
30-45 minutes groups (96.5% vs. 94.5%). Patients with DIDO 90 were less likely to
have a culprit artery which required an intervention. When adjusted for difference in
baseline characteristics, there were no differences in 30 day or 1 year mortality.
Conclusions: DIDO time is a complex measure influenced by many factors. There is
with basically no difference in clinical outcomes for patients with DIDO 30 compared
to 30-45 minutes. Clinical outcomes appear to be more related to factors which increase
DIDO time than the time itself.
DIDO 0-30
(n279)
DIDO 31-45
(n649)
DIDO 46-60
(n651)
DIDO 60-90
(n613)
DIDO>90
(n374) P-value
Age (Yrs), (Mean (SD)) 60.5 (13.1) 61.4 (13.8) 62.0 (14.0) 64.1 (14.7) 63.7 (14.9) 0.001
Male (N/%) 208/74.6% 482/74.3% 469/72.0% 428/69.8% 259/69.3% 0.25
Diabetes Mellitus (N/
%)
42/15.1% 86/13.3% 101/15.6% 115/18.8% 74/19.8% 0.027
Initial Hospital Zone 1
(N/%)
213/76.3% 476/73.7% 372/57.1% 291/47.6% 177/47.5% 0.001
Presentation to ANW
during traditional
peak hours (N/%)
120/43.2% 234/36.1% 229/35.2% 196/32.0% 115/30.8% 0.008
Mode of Arrival IH—
Ambulance (N/%)
189/67.7% 251/38.7% 229/35.2% 217/35.4% 105/28.1% 0.001
Prior ED Activation
(N/%)
45/16.1% 65/10.0% 49/7.53% 27/4.4% 26/7.0% 0.001
Cardiac Arrest—Pre
PCI & In Cath (N/%)
28/10.04% 69/10.63% 72/11.06% 84/13.7% 38/10.16% 0.50
Cardiogenic shock
(N/%)
20/7.3% 40/6.4% 56/8.8% 61/10.2% 35/9.5% 0.13
Intervention
performed (N/%)
242/86.74% 543/83.67% 519/79.72% 467/76.18%250/66.84% 0.001
Door to Balloon 
120 minutes (%) (95%
Wald CL)
96.5%
(21.5,
100)a
94.5%
(21.3, 100)a
84.1%
(18.9, 100)a
46.0%
(10.2, 100)b
3.6% (1.7,
7.5)c
0.001†
30 day mortality, (%)
(95% Wald CL)*
4.8% (0.6,
36.0)
6.5% (1.1,
37.8)
5.7% (1.0,
33.1)
5.3% (0.9,
30.2)
11.5%
(3.4,
38.2)
0.18
1 year mortality (%)
(95% Wald CL)**
5.5%
(0.9%,
32.0%)
8.0% (1.7%,
38.3%)
6.8% (1.4%,
32.8%)
8.4% (1.8%,
39.2%)
10.2%
(3.3%,
31.5%)
0.27
abcEstimates with the same superscripts do not differ (p0.05)
*Mortality rates adjusted for baseline differences of age, intervention performed, cardiac arrest, and
cardiogenic shock
**Mortality rates adjusted for age, intervention performed, arrival mode to tertiary hospital, cardiac
arrest, and cardiogenic shock, and cardiac arrest “Cool-It” patient
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Background: Fibrinolysis has not been used for the treatment of ST-segment elevation
myocardial infarction (STEMI) in Denmark since 2005. The aim of the present study was
to assess the positive predictive value of clinically suspected STEMI among consecutive
patients in a real-world setting where all patients with suspected STEMI undergo acute
coronary angiography.
Methods: We evaluated the clinical diagnosis of consecutive patients with suspected
STEMI admitted to Aarhus University Hospital between September 1, 2010 and August
31, 2011 who underwent acute angiography. Conclusive STEMI was defined as a patient
with an, by angiography, identifiable culprit lesion.
Results: Of 615 patients with suspected STEMI, 483 (79%) had conclusive STEMI while
132 (21%) did not have an identifiable culprit lesion. Patients with conclusive STEMI had
a higher proportion of male gender (73% versus 60%; P0.004), advanced age (mean, 64
versus 62 years; P0.005), and a lower ejection fraction (47% versus 50%; P0.003).
Patients without conclusive STEMI were more likely to have diabetes (16% versus 10%;
P0.04), left bundle branch block (24% versus 2%; P0.001), hypertension (48% versus
36%; P0.01), or a history of coronary artery bypass surgery (8% versus 2%; P0.001).
Among patients without conclusive STEMI, 41% had positive biomarkers and a number
of differential diagnoses were identified.
Conclusions: In this real-world setting, the positive predictive value of clinically
suspected STEMI was 79%. A substantial number of “false-positive” patients would have
received fibrinolysis if acute angiography had not been available.
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Background: Tragic magnitude 9.0 earthquake hit Northeast Japan on 11 March 2011.
Even at Medical center in Chiba prefecture which is located 400 km away from a
hypocenter have experienced a strong quake. City‘s function was thrown into confusion
for couple of days, but not so many people were reported to be dead in our medical district
and population change was limited. According to the past statistics, in such a disastrous
situation, tend to increase acute myocardial infarction (AMI) patients. Our objective was
to investigate whether disaster stress will increase AMI patients.
Methods: Retrospective study was performed at Funabashi Municipal Medical Center,
Division of Cardiology, Heart and Vessel Institute, Chiba, Japan. We have compared 307
patients who were hospitalized for AMI between Mar11th to Aug 10th (6 month period)
for years 2006 to 2012. For year 2012, only March to June data was included. Monthly
figure stands for 11th of the month to 10th of next month. The age was from 32 to 92
(mean 67.611.7) and gender were Male 250 and Female 57. Study was made between
2006 to 2010 plus 2012 group and 2011 group.
Results: The number of AMI patient for 2011 March was 15 (14 underwent percutaneous
coronary intervention) and average for 2006 to 2010 plus 2012 group was only at 5.7. The
AMI number after catastrophe increased by 163% and strong correlation between the
number of aftershock and AMI were seen. There were no significant difference between
groups in age, gender, coronary risk factors, culprit lesion and mean blood pressure at
arrival.
Number of
AMI
patients Mar Apr May Jun Jul Aug
2006 5 7 4 8 4 2
2007 5 13 4 7 15 8
2008 4 12 6 4 8 8
2009 9 4 9 15 10 9
2010 6 12 8 7 8 11
2012 5 11 9 - - -
2006-2010
& 2012
average
5.7 9.8 6.7 8.2 9 7.6
2011
(change%)
15
(163%)
4
(59%)
10
(49%)
7
(15%)
6
(33%)
8
(5%)
Conclusions: This study demonstrates that disaster stress might be the risk factor for
AMI and increases hospitalized patients. Also we have experienced the importance of PCI
facility running after the catastrophe since number of patients will increase. Over all,
further investigation using large number of cases is necessary. Multiple center investiga-
tion is required.
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Background: High-density lipoprotein-cholesterol (HDL-C) is a continuous inverse
cardiovascular risk factor. However, little is known about the influence of HDL-C on
outcome of patients with acute coronary syndrome (ACS) undergoing percutaneous
coronary intervention (PCI).
Methods: A total of 2169 consecutive patients with ACS underwent elective PCI was
enrolled. We evaluated the impact of HDL-C on 1-year occurrence of death, non-fatal
myocardial infarction and target lesion revascularization. The patients were divided into
2 groups: high HDL-C ( 50 mg/dL for female and  40 mg/dl for male) and low
HDL-C ( 50 mg/dL for female and  40 mg/dl for male).
Results: patients with high HDL-C had a higher incidence of male and hypercholester-
olemia. After correction for baseline differences, patients with high HDL-C had a
significant lower 1-year outcome (OR 0.567, 95% CI 0.402-0.799, p0.001).
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Conclusions: Independent of low-density lipoprotein-cholesterol, HDL-C was associated
with better 1-year outcome in patients with ACS underwent elective PCI.
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Background: Longitudinal stent deformation (LSD) is a recently described
complication of PCI but mechanisms contributing to its occurrence and associated
clinical outcomes remain unclear. The FDA Manufacturer and User Facility
Device Experience (MAUDE) database is a voluntary international electronic
reporting system whose aim is to capture major adverse events involving medical
devices. We sought to identify cases of LSD reported to this database to gain
insight into procedural and anatomical factors that predispose to this complication
and associated clinical outcomes.
Methods: The MAUDE database was searched from 1992 until 31st October 2011
using 11 defined search terms. Individual reports identified using this search
strategy were studied for the presence of longitudinal stent deformation, defined
as the distortion or shortening of a stent in the longitudinal axis following
successful stent deployment.
Results: 57 unique cases of LSD were identified between 2004-2011. A significant
increase in the reporting of LSD in the last two years was observed with most reported
cases in stents based on the Element platform (90%). The lesions in which LSD was
reported were complex (vessel calcification 26%; tortuosity 25%; long 28%; ostial disease
21%) and most frequently occurred following attempts to pass or withdraw secondary
devices through a previously deployed stent (89% cases where mechanism identified).
The majority of cases required further treatment (79%) with further stent deployment
performed in 58% cases and balloon post-dilatation alone performed in 18% cases.
Adverse clinical outcomes including emergent cardiac surgery and acute and sub-acute
stent thrombosis occurred in 8 cases.
Conclusions: LSD is reported most commonly in cases of complex angiographic
disease. This complication can occur secondary to a variety of mechanisms and
identification and treatment is important, since adverse incidents such as emergent
CABG and stent thrombosis may occur. The recent increased reporting of this
complication appears to be related to the introduction of the Element stent
platform. A novel classification system is proposed to facilitate future reporting of
this complication.
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Background: Significant longitudinal compression has been clinically observed in cases
where drug-eluting coronary stents were crossed by other interventional devices. Our
objective was to characterize stent longitudinal resistance under simulated clinical worst
case crossing scenarios in good apposition and malapposition in-vitro models.
Methods: 6 commercially available coronary balloon-expandable stent designs were
evaluated. First direct parallel plates longitudinal crush resistance was conducted after
deploying 3 samples/design to 3 mm diameter. Then 12 samples/design were tracked over
a 0.014 interventional guidewire, positioned and deployed in either good apposition or
malapposition coronary vessel models, 6 samples each, respectively. After deployment and
withdrawal of the balloon, a new balloon was advanced over the guidewire automatically using
the IDTE 2000 (Interventional Device Testing Equipment, Machine Solutions, Inc, Flagstaff,
AZ, USA). For each sample, the force required to track the balloon through the stent and the
change in stent length after balloon crossing were both calculated.
Results: In the parallel plate crush test, 3 out of 6 stent designs demonstrated higher
longitudinal crush rates compared to the Resolute, Medtronic, Minneapolis USA (Promus
Element, Boston Scientific Corp., Natik USA & Coroflex Blue, BBraun, Melsungen
Germany, p0.001; Orsiro, Biotronik, Berlin Germany, p0.038). In the simulated use test,
longitudinal crush ranged from 5 to 22%; however, no statistically significant differences in
longitudinal crush were seen between stent types for both good apposition (p0.836) and
malapposition cases (p0.447). One stent type showed significantly higher longitudinal crush
(p0.027) in the malapposed model compared to the good apposition model.
Conclusions: Lower resistance to pure mechanical longitudinal crush of some stent
designs seen in bench testing did not correlate to significantly higher crush rates in good
simulated clinical conditions. Nevertheless, it would be useful to take account the rough
mechanical characteristics of some new stents to minimize longitudinal compression
during stent implantation.
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Background: Stent fracture (SF) has been frequently reported in clinical trials and it has
been associated with restenosis and thrombosis. In this study we aimed to determine the
predictors of stent fracture by using a single stent design in the porcine coronary model.
Methods: A total of 113 Cypher stents were implanted in normal coronary arteries at a
10% overstretch ratio in a single (81.4%), overlapping (30.6%) or T-bifurcation (19.4%)
stent configuration. At termination, we reviewed high-contrast film–based radiographs to
examine for the presence of SF. SF was graded as minor (2 SF), multiple (2 SF) and
major (multiple SF with complete transection or SF at multiple sites). Angiographic and
histo-morphometric data were compared between groups with SF and without SF
(non-SF).
Results: SF was found in 11 stents (9.5%; minor 3(27.3%), multiple 3(27.3%), and
major  5(45.5%)). SF was more commonly seen in longer stents (SF 19.94.8 mm
versus non-SF 14.33.2 mm, p0.001), T-bifurcation location (SF: 68.8% versus
non-SF: 10.9%, p0.001) and overlapping stents (SF: 75.0% versus non-SF: 22.8%,
p0.001). Angiographic restenosis (50%) was higher in the SF (33.3%) group
compared to non-SF (4.3%, p0.016) and it was found only on the multiple (1 of 3) or
major (2 of 5) SF groups. The presence of SF was associated with a greater degree of
histologically derived neointimal proliferation (neointimal area SF: 3.422.63 mm2
versus non-SF: 2.621.79 mm2 and % area stenosis SF: 43.119.5% versus non-SF:
36.620.6%). T-bifurcation location (OR [95%CI] 80.81[9.42, 693.52], p0.001) and
stent overlapping (OR [95%CI]  46.18[5.44, 391.72], p0.001) were identified as
independent predictors of SF.
Conclusions: At the experimental setting, the incidence of SF found was high. Specific
technical situations (i.e., overlapping stents) were predictors of SF and were associated to
higher degrees of neointimal proliferation. SF may be a strong contributor of stent failure
in complex technical situations.
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